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Objectives: endothelin 1,2 plays a significant role in the process of atherogenesis and vascular wall injury. The aim of
this study was to assess whether plasma endothelin 1,2 levels were elevated in patients with large or symptomatic
abdominal aortic aneurysms (AAAs).
Design: a prospective open study.
Materials and methods: plasma endothelin 1,2 levels were measured in 65 consecutive patients with infrarenal aortic
aneurysms and compared with the levels in 44 healthy volunteer controls. The data for abdominal aneurysm patients
was analysed in four subgroups: (i) small aneurysms (<5 cm), (ii) large aneurysms ([5 cm), (iii) asymptomatic aneurysms
and (iv) symptomatic aneurysms. Comparisons were made between endothelin 1,2 levels in aneurysm patients and
controls and between the different aneurysm subgroups.
Results: a highly significant difference (p<0.0001) was found between aneurysm patients and controls. Patients with
large aneurysms had significantly higher levels than patients with small aneurysms (p<0.01). There was no statistical
difference in endothelin 1, 2 levels between symptomatic and asymptomatic patients; however, the highest levels were
found in large, symptomatic aneurysms and the lowest in small, asymptomatic aneurysms.
Conclusions: plasma endothelin 1,2 is an endogenous marker of aneurysm diameter. Further studies are required to
determine whether it relates to the rate of growth of aneurysms.
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Introduction preferentially abluminally towards smooth-muscle
cells. Physiological blood levels are low. Patho-
The aetiology of abdominal aortic aneurysm (AAA) physiological changes in the endothelium play an
important role in the process of destruction and re-is multifactorial. Although previous studies1–3 have
documented the influence of atherosclerotic ob- modelling the vessel wall during aneurysm formation.
This study tests the hypothesis that plasma endothelinliterative disease on vessel wall degeneration in an-
eurysmal disease, there are significant differences 1,2 levels are related to the process of aneurysm for-
mation.between the two conditions. In particular, the tunica
media is thinner in the wall of aortic aneurysms and the
medial integrity of the wall is destroyed in aneurysms,
while it is preserved in atherosclerotic obliterative
disease.4,5 Many studies have described the influence
Material and Methodsof age, gender, genetic, demographic and other fac-
tors6–9 on the development of aortic aneurysms. Recent
Plasma endothelin 1,2 levels were measured in 65studies have concentrated on enzymatic processes in
consecutive patients with abdominal aortic aneurysmsthe wall of aortic aneurysms.10–14
and 44 healthy volunteer controls. The mean age ofEndothelial cells produce several factors which initi-
the aneurysm patients was 67.4 (range 51–84) years,ate several processes in the vascular wall.15 Endothelin
with a male to female ratio of 4:1; 65% were smokers,is an endothelium-derived contracting factor released
25% diabetics, 35% hypertensive and 26% had hyper-
lipidaemia. Thirty-three patients had asymptomatic
* Please address all correspondence to: V. Trˇesˇka, Department of aneurysms and 32 were symptomatic with the presenceSurgery, University Hospital, Dr. E. Benesˇe 13, 305 99 Plzenˇ, Czech
Republic. of abdominal or back pain, gastrointestinal symptoms
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Table 1. Patients’ characteristics.
AAA n=65 Age 67.4 yrs (51–84)
M:F 4:1
Smokers 42 (64.6%)
Diabetes 16 (24.6%)
Hypertension 23 (35.4%)
Hyperlipidaemia 17 (26.2%)
Controls n=44 Age 63.4 yrs (43–88)
M:F 3:1
AAA, abdominal aortic aneurysm; M, males; F, females.
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Fig. 1. pET 1,2 in AAA and control group. I, small; II, large; III,
asymptomatic; IV, symptomatic.
or lower extremity ischaemia from peripheral em-
bolisation. No patient with an AAA rupture was in-
cluded in this study. The control group had a mean
of size of aneurysm or symptoms (Fig. 1). Endothelinage of 64.3 (range 43–88) years with a male to female
1,2 levels did not relate gender, smoking, hypertension,ratio of 3:1 (Table 1). The aneurysm diameter was
diabetes or hyperlipidaemia in patients with an-measured by a single experienced ultrasonographer
eurysms (Table 2).using a B-mode sector scanner. Anteroposterior and
In patients with aortic aneurysms the highest levelstransverse measurements were made and the highest
were found in patients with large symptomatic an-diameter of AAA was calculated. The accuracy for
eurysms. The difference between large and small an-repetitive measurement was–0.2 cm; 23 patients were
eurysms was statistically significant, but endothelin 1,classified as having a small aneurysm (<5 cm; range
2 levels did not distinguish between symptomatic3.5–4.8 cm) and 42 patients a large aneurysm ([5 cm;
and asymptomatic aneurysms (Table 3i). Comparingrange 5.3–10.2 cm).
aneurysm patients with controls (using the WilcoxonVenous blood samples were taken without tour-
test with a cut off at 12.5 pmol/l) the sensitivity forniquet from the ante-cubital vein at a standard time
aneurysm patients was 80% with a specificity forin the morning to minimise diurnal variation. Plasma
controls of 90.9% (Table 3ii).endothelin 1,2 levels were determined by using the
Endothelin 1,2 assay system (Amersham, U.K.). This
system permits quantitative determination of en-
dothelin 1 and endothelin 2. The cross-reactivity of
Discussionendothelin 1, endothelin 2, endothelin 3 and big en-
dothelin 1 in this assay was 100; 204; 0.0024 and 37.9 The incidence of abdominal aortic aneurysms con-per cent respectively. tinues to increase,16,17 with centres in the U.S.A. andStatistical analysis was performed using the non- the U.K. documenting increases in the incidence of upparametric Wilcoxon test for analysis of differences to seven-fold.18–20 The prevalence is particularly risingbetween groups with a non-normal distribution (dem- in males over the age of 55 years, and it is a leadingonstrated by normality distribution testing using the vascular cause of death in the U.S.A. and WesternLilliefors version of the Kolmogorov–Smirnov test). Europe.21Sensitivities and specificities were calculated to test the Aneurysms have a complex aetiology with numer-value of plasma endothelin 1,2 levels in distinguishing ous factors involved to greater or lesser extent but nodifferent groups. Values were expressed as a single main factor. Several local and systemic fac-mean–s.d. Statistical significance was assumed for a tors22–24 dynamically interact in the process. Recent
p value <0.05. investigations have focused on elastin-degrading en-
zymes and their inhibitors in the aneurysm wall25,26
and elastin degradation may be a key factor in the
early stages of aneurysm formation. The detection of
biochemical changes in the initial phase of aneurysm
formation might identify patients with early aneurysmResults
or those at risk of developing aneurysms. Plasma levels
might indicate those aneurysms at risk of expansionPatients with aneurysms had significantly higher
plasma endothelin 1,2 levels than controls irrespective or rupture. Understanding the changes occurring may
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Table 2. Risk factors and plasma endothelin 1,2 levels.
M/F S/NS H/N DM/NDM HL/NL
ET 1,2 25.8–16.1 22.6–19.2 21.2–18.4 25.1–16.2 26.9–15.9
(pmol/l) 22.9–14.8 24.7–12.8 25.3–14.4 24.0–13.7 19.8–18.4
Wilcoxon test n.s. n.s. n.s. n.s. n.s.
M, males; F, females; S, smokers; NS, non-smokers; H, hypertonics; N, normotonics; DM,
diabetics; NDM, non-diabetics; HL, hyperlipidaemia; NL, normal lipid levels.
Table 3(i). Plasma endothelin 1,2 levels (pmol/l) in patients with AAA.
All AAA (n=65) Small (n=23) Large (n=42)
26.0–13.6 19.5–12.2 29.5–13.2
Asymptomatic (n=33) Subgroup I (n=10) Subgroup III (n=23)
23.2–11.2 19.2–13.4 24.9–9.8
Symptomatic (n=32) Subgroup II (n=13) Subgroup IV (n=19)
28.9–15.3 19.8–11.4 35.1–14.8
Control (n=44)
8.3–3.0
Subgroup I, small asymptomatic; Subgroup II, small symptomatic; Subgroup
III, large asymptomatic; Subgroup IV, large symptomatic.
Table 3(ii). Statistical analysis.
Group Wilcoxon Cut-off Specificity Sensitivity
A·B test
All AAA·control p<0.0001 12.5 90.9 80.0
Subgroup I·control p<0.0001 12.5 90.9 60.0
Subgroup II·control p<0.0001 12.5 90.9 61.5
Subgroup III·control p<0.0001 12.5 90.9 87.0
Subgroup IV·control p<0.0001 12.5 90.9 94.7
Small·large p<0.01 32.3 91.3 40.5
Asymptomatic·symptomatic p<0.13 36.3 90.9 25.0
Subgroup I·Subgroup II p<0.8 34.8 90.0 0.0
Subgroup III·Subgroup IV p<0.02 36.3 91.3 42.1
Subgroup I, small asymptomatic; Subgroup II, small symptomatic; Subgroup III, large
asymptomatic; Subgroup IV, large symptomatic.
Specificity is the estimation of probability that a patient is in group B if plasma endothelin
1,2 is Zcut off. Cut-off is estimated to make specificity as near 90% as possible. Sensitivity
is the estimation of probability that a patient is in group A if plasma endothelin 1,2 level
is cut off.
indicate ways in which the progress of aneurysms of proteolysis and atherogenesis in the arterial wall.
Studies have shown the effect of endothelin in patientsmight be modified.
Endothelin is produced by endothelial cells and its with essential and secondary hypertension.34,35 Stimu-
lation of type A endothelin receptors on smooth musclerelease abluminally or into the circulation is stimulated
by a variety of factors such as adrenaline, angiotensin cells causes vasoconstriction while type B receptors
mediate the production of vasodilators, prostacyclinII, vasopressin, hypoxia and vascular injury.27–29 It is
released in increased amounts by changes in shear and nitric oxide.36,37
This study investigated plasma endothelin 1,2 levelsstress of the vessel wall and especially by hypoxia.30
Some of these processes play an important part in the in patients with aortic aneurysm to see if there was a
correlation between aneurysm size or symptomatologypathogenesis of aneurysms.31 Endothelin has a number
of biological functions and exists in three forms, of and plasma levels. It demonstrated a significant eleva-
tion of plasma endothelin levels in aneurysm patientswhich endothelin 2 is the most potent vasoconstrictor,
followed by endothelins 1 and 3.32,33 Endothelin has compared to healthy age and sex-matched controls,
and in large aneurysms compared to small aneurysms.been reported to release several hormones, endo-
thelium-derived relaxing factor, noradrenaline and Symptomatic aneurysms may also have elevated levels
compared to asymptomatic aneurysms. It is not clearatrial natriuretic peptide. It contributes to the process
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how these raised levels relate to the pathogenesis of the growing AAA, and the resulting hypoxia may then
cause the higher endothelin 1,2 secretion.aneurysms. It is possible that they relate to vessel wall
The small aneurysms had significantly lower plasmainjury (atherosclerosis, inflammation) in the process
endothelin 1,2 levels than large AAA, but the clinicalof aneurysm formation. It may be that the raised levels
applicability was not very high because the sensitivityrelate to the risk factors for aneurysm formation and
for the large AAA was only 40.5%. Nevertheless, thethat might be supported by the low levels found in
higher endothelin 1,2 levels in patients with largerthe control group with low-risk factors although there
diameter aortic aneurysms may indicate a prognosticwas no statistical correlation between risk factors and
significance for aneurysms under follow-up. In generalplasma endothelin levels in the aneurysm group.
high endothelin 1,2 plasma levels in patients can in-A more direct role for endothelin may be in an-
dicate the presence of an AAA. This could be veryeurysm formation and enlargement. It plays a role in
helpful especially in small AAAs, which can be de-the stimulation of smooth-muscle cells and in the
tected only with very great difficulty by clinical ex-creation of atherosclerotic plaque. It takes part in the
amination. Further studies of changing endothelinprocess of proteolysis of the extracellular matrix which
levels in aneurysms under surveillance are requiredleads on the one hand to atherosclerotic plaque de-
to test these hypotheses.stabilisation and on the other hand to dilatation and
degeneration of the aortic wall.38 Macrophages which
adhere in a significant amount to the injured regions
of the AAA wall have also been shown to produce
endothelin.39 The role of released endothelin is unclear. References
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